当前位置:首页 - 行情中心 - 研奥股份(300923) - 财务分析 - 利润表

研奥股份

(300923)

  

流通市值:18.77亿  总市值:19.32亿
流通股本:7635.60万   总股本:7860.00万

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入92,271,859.98471,448,384.22280,254,773.64199,937,110.87
营业收入92,271,859.98471,448,384.22280,254,773.64199,937,110.87
利息收入--0-
已赚保费--0-
手续费及佣金收入--0-
二、营业总成本86,163,623.47423,831,440.82261,600,982.66180,907,806.94
营业成本68,937,924.4348,459,753.29204,745,781.36142,101,075.89
利息支出--0-
手续费及佣金支出--0-
退保金--0-
赔付支出净额--0-
提取保险合同准备金净额--0-
保单红利支出--0-
分保费用--0-
税金及附加1,039,010.344,756,892.132,972,437.092,367,713.3
销售费用3,684,936.6615,846,320.315,596,464.710,092,056.12
管理费用7,479,097.3933,219,349.6823,032,503.216,120,127.42
研发费用5,191,827.9522,401,627.8515,916,321.6210,676,986.22
财务费用-169,173.27-852,502.43-662,525.31-450,152.01
其中:利息费用55,514.2198,435.28115,218.7877,338.36
其中:利息收入241,761.991,191,574.26883,287.07626,299.75
加:公允价值变动收益-310,972.60-
加:投资收益556,947.014,231,379.553,197,817.522,046,177.42
净敞口套期收益--0-
汇兑收益--0-
资产处置收益-87,631.17185,921.31173,436.43161,860.15
资产减值损失(新)110,872.75-3,902,578.4-4,670,666.85-4,580,686.32
信用减值损失(新)-2,034,000.66-5,302,202.371,552,370.05215,817.05
其他收益1,212,256.362,879,766.941,583,546.411,236,662.11
营业利润平衡项目0000
四、营业利润5,866,680.846,020,203.0320,490,294.5418,109,134.34
加:营业外收入2,744.9695,167.2290,049.6961,718.86
减:营业外支出11,579.2797,534.5949,013.0440,689.15
利润总额平衡项目0000
五、利润总额5,857,846.4946,017,835.6620,531,331.1918,130,164.05
减:所得税费用1,278,989.973,671,072.011,725,825.51,709,384.7
六、净利润4,578,856.5242,346,763.6518,805,505.6916,420,779.35
持续经营净利润4,578,856.5242,346,763.6518,805,505.6916,420,779.35
终止经营净利润--0-
归属于母公司股东的净利润4,578,856.5242,346,763.6518,805,505.6916,420,779.35
少数股东损益--0-
(一)基本每股收益0.060.540.240.21
(二)稀释每股收益0.060.540.240.21
八、其他综合收益--14,050,945.69-7,025,472.85-7,025,472.85
归属于母公司股东的其他综合收益--14,050,945.69-7,025,472.85-7,025,472.85
九、综合收益总额4,578,856.5228,295,817.9611,780,032.849,395,306.5
归属于母公司股东的综合收益总额4,578,856.5228,295,817.9611,780,032.849,395,306.5
归属于少数股东的综合收益总额--0-
公告日期2025-04-212025-04-212024-10-252024-08-28
审计意见(境内)标准无保留意见
TOP↑